We also examined the baseline tumor size, blood CD8+ and CD4+ T cells proportions, and plasma IFN-γ levels in different response groups and did not observe a significant difference (Figures 2C–F; Supplementary Table S2). This evidence concerns the gene IFNG and neoplasm.